Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb;476(2):971-989.
doi: 10.1007/s11010-020-03964-8. Epub 2020 Nov 22.

The role of labile Zn2+ and Zn2+-transporters in the pathophysiology of mitochondria dysfunction in cardiomyocytes

Affiliations
Review

The role of labile Zn2+ and Zn2+-transporters in the pathophysiology of mitochondria dysfunction in cardiomyocytes

Belma Turan et al. Mol Cell Biochem. 2021 Feb.

Erratum in

Abstract

An important energy supplier of cardiomyocytes is mitochondria, similar to other mammalian cells. Studies have demonstrated that any defect in the normal processes controlled by mitochondria can lead to abnormal ROS production, thereby high oxidative stress as well as lack of ATP. Taken into consideration, the relationship between mitochondrial dysfunction and overproduction of ROS as well as the relation between increased ROS and high-level release of intracellular labile Zn2+, those bring into consideration the importance of the events related with those stimuli in cardiomyocytes responsible from cellular Zn2+-homeostasis and responsible Zn2+-transporters associated with the Zn2+-homeostasis and Zn2+-signaling. Zn2+-signaling, controlled by cellular Zn2+-homeostatic mechanisms, is regulated with intracellular labile Zn2+ levels, which are controlled, especially, with the two Zn2+-transporter families; ZIPs and ZnTs. Our experimental studies in mammalian cardiomyocytes and human heart tissue showed that Zn2+-transporters localizes to mitochondria besides sarco(endo)plasmic reticulum and Golgi under physiological condition. The protein levels as well as functions of those transporters can re-distribute under pathological conditions, therefore, they can interplay among organelles in cardiomyocytes to adjust a proper intracellular labile Zn2+ level. In the present review, we aimed to summarize the already known Zn2+-transporters localize to mitochondria and function to stabilize not only the cellular Zn2+ level but also cellular oxidative stress status. In conclusion, one can propose that a detailed understanding of cellular Zn2+-homeostasis and Zn2+-signaling through mitochondria may emphasize the importance of new mitochondria-targeting agents for prevention and/or therapy of cardiovascular dysfunction in humans.

Keywords: Aging; Heart; Hyperglycemia; Hyperinsulinemia; Mitochondria; Zinc; Zinc-transporters.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ernster L, Schatz G (1981) Mitochondria: a historical review. J Cell Biol 91:227s–255s. https://doi.org/10.1083/jcb.91.3.227s - DOI - PubMed
    1. Yang D, Oyaizu Y, Oyaizu H, Olsen GJ, Woese CR (1985) Mitochondrial origins. Proc Natl Acad Sci U S A 82:4443–4447. https://doi.org/10.1073/pnas.82.13.4443 - DOI - PubMed - PMC
    1. Gray MW, Burger G, Cedergren R, Golding GB, Lemieux C, Sankoff D, Turmel M, Lang BF (1999) A genomics approach to mitochondrial evolution. Biol Bull 196:400–403. https://doi.org/10.2307/1542980 - DOI - PubMed
    1. Gustafsson AB, Gottlieb RA (2008) Recycle or die: the role of autophagy in cardioprotection. J Mol Cell Cardiol 44:654–661. https://doi.org/10.1016/j.yjmcc.2008.01.010 - DOI - PubMed - PMC
    1. Hoppel CL, Tandler B, Fujioka H, Riva A (2009) Dynamic organization of mitochondria in human heart and in myocardial disease. Int J Biochem Cell Biol 41:1949–1956. https://doi.org/10.1016/j.biocel.2009.05.004 - DOI - PubMed - PMC

LinkOut - more resources